The number of people with susceptibility test result for rifampicin in Jordan
Jordan: The number of people with susceptibility test result for rifampicin was 78.48 in 2021. ▲ Rising
Latest (2021)
78.48
Change on year
down 21.5%
World rank
97th
of 146 countries
All-time high
100
in 2019
All-time low
47.98
in 2017
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Jordan, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
In 2021, the number of people with susceptibility test result for rifampicin in Jordan stood at 78.48.
Compared with earlier readings it is down 21.5% on the previous year and up 63.6% over five years.
That places Jordan 97th out of 146 countries with data for 2021, putting it in the middle of the range.
The number of people with susceptibility test result for rifampicin in Jordan, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 47.98 | — |
| 2018 | 73.44 | +53.1% |
| 2019 | 100 | +36.2% |
| 2020 | 100 | +0.0% |
| 2021 | 78.48 | -21.5% |
Jordan compared with similar countries
- Jordan's 78.48 is below the median for upper middle income countries, which is 92.7, 85% of the median. (45 countries reporting)
- Jordan's 78.48 is below the median for Middle East, North Africa, Afghanistan & Pakistan, which is 89, 88% of the median. (15 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 73.8 | 47.98 | 100 | 3 |
| 2020s | 89.24 | 78.48 | 100 | 2 |
Countries ranked near Jordan
More health data for Jordan
- Un projection of annual infant deaths, annual growth rate -1.67 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.9463 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 842.7 deaths per 1,000 people (2090)
- Number of infants who die before age 1 470 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -2 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.048 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.13 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Jordan?
- The number of people with susceptibility test result for rifampicin in Jordan was 78.48 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Jordan?
- The highest recorded value was 100 in 2019.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Jordan?
- The lowest recorded value was 47.98 in 2017.
- How does Jordan rank for the number of people with susceptibility test result for rifampicin?
- Jordan ranks 97th out of 146 countries with data for 2021.
- Where does this Jordan data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).